- Report
- September 2024
- 100 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- May 2024
- 140 Pages
Global
From €5953EUR$6,499USD£5,060GBP
- Report
- May 2024
- 128 Pages
Global
From €5953EUR$6,499USD£5,060GBP
- Report
- March 2024
- 397 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- April 2024
- 160 Pages
Global
From €4552EUR$4,969USD£3,869GBP
- Report
- May 2025
- 50 Pages
Global
From €2428EUR$2,650USD£2,063GBP
Asenapine is a medication used to treat mental disorders such as schizophrenia and bipolar disorder. It is a type of antipsychotic drug, which works by blocking certain receptors in the brain that are associated with psychotic symptoms. Asenapine is available in both oral and sublingual forms, and is generally taken twice daily. It is generally well-tolerated, with the most common side effects being drowsiness, dizziness, and weight gain.
Asenapine is a relatively new drug, having been approved by the FDA in 2009. It is used as an alternative to other antipsychotic medications, such as risperidone and olanzapine, due to its lower risk of side effects. It is also used as an adjunct to other medications, such as mood stabilizers, to help manage symptoms of mental disorders.
The asenapine market is highly competitive, with several major pharmaceutical companies offering the drug. These include Merck & Co., Inc., Sunovion Pharmaceuticals, Inc., and Teva Pharmaceuticals USA, Inc. Show Less Read more